|Bid||4.71 x 1000|
|Ask||4.73 x 1000|
|Day's Range||4.33 - 4.76|
|52 Week Range||1.74 - 6.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 4, 2017 - May 8, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
NEW YORK, NY / ACCESSWIRE / May 23, 2018 / U.S. markets fell Tuesday on geopolitical concerns after President Trump stated he was not happy with the current U.S. – China trade talks. The Dow Jones Industrial ...
Geron Corporation (GERN) today announced that an abstract describing clinical data regarding the telomerase inhibitor imetelstat has been selected for an oral presentation at the 23rd Congress of the European Hematology Association (EHA) to be held in Stockholm, Sweden from June 14-17, 2018. The abstract contains updated data (as of January 2018) from the first 32 patients enrolled in Part 1 of IMerge, the ongoing Phase 2/3 clinical trial of imetelstat in patients with lower risk myelodysplastic syndromes (MDS) being conducted by Janssen Research & Development, LLC.
NEW YORK, May 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of H&R ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 10) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. (NYSE: ...
The Menlo Park, California-based company said it had a loss of 4 cents per share. The drugmaker posted revenue of $318,000 in the period. In the final minutes of trading on Thursday, the company's shares ...
MENLO PARK, Calif., May 10, 2018-- Geron Corporation today reported financial results for the first quarter ended March 31, 2018.. For the first quarter of 2018, the company reported operating revenues ...
NEW YORK, NY / ACCESSWIRE / May 7, 2018 / U.S. markets rallied on Friday, despite trade uncertainties and weak employment data, as a surge in Apple led to strong gains by the tech sector. The Dow Jones ...
With no approved product in Geron's (GERN) portfolio, investor focus continues to remain on its sole pipeline candidate, imetelstat, ahead of the first-quarter earnings release.
In this article, I will take a quick look at Geron Corporation’s (NASDAQ:GERN) recent ownership structure – an unconventional investing subject, but an important one. Ownership structure has been foundRead More...
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action as money flows show a move back to U.S. equities, but out of high yield and emerging markets. Combined with the rising dollar, crude oil prices and Treasury bond yields, BAML is warning of headwinds for risk markets.
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market moves.
Alan Valdes of Silverbear Capital joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action after Virtu Financial reported first quarter earnings.
Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action.